DE3886592D1 - Präparate zur Behandlung von Beschwerden der Wurzelhaut der Zähne. - Google Patents

Präparate zur Behandlung von Beschwerden der Wurzelhaut der Zähne.

Info

Publication number
DE3886592D1
DE3886592D1 DE88305572T DE3886592T DE3886592D1 DE 3886592 D1 DE3886592 D1 DE 3886592D1 DE 88305572 T DE88305572 T DE 88305572T DE 3886592 T DE3886592 T DE 3886592T DE 3886592 D1 DE3886592 D1 DE 3886592D1
Authority
DE
Germany
Prior art keywords
treatment
complaints
roots
preparations
teeth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88305572T
Other languages
English (en)
Other versions
DE3886592T2 (de
Inventor
Richard I Vogel
Guo-Chen Yeh
Franck J Sena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Block Drug Co Inc
Original Assignee
Block Drug Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Block Drug Co Inc filed Critical Block Drug Co Inc
Publication of DE3886592D1 publication Critical patent/DE3886592D1/de
Application granted granted Critical
Publication of DE3886592T2 publication Critical patent/DE3886592T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE88305572T 1987-06-18 1988-06-17 Präparate zur Behandlung von Beschwerden der Wurzelhaut der Zähne. Expired - Fee Related DE3886592T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/063,324 US5225441A (en) 1987-06-18 1987-06-18 Treatment of periodontal disease

Publications (2)

Publication Number Publication Date
DE3886592D1 true DE3886592D1 (de) 1994-02-10
DE3886592T2 DE3886592T2 (de) 1994-04-07

Family

ID=22048438

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88305572T Expired - Fee Related DE3886592T2 (de) 1987-06-18 1988-06-17 Präparate zur Behandlung von Beschwerden der Wurzelhaut der Zähne.

Country Status (8)

Country Link
US (1) US5225441A (de)
EP (1) EP0295954B1 (de)
JP (1) JP2722204B2 (de)
AT (1) ATE99171T1 (de)
AU (1) AU607509B2 (de)
CA (1) CA1330046C (de)
DE (1) DE3886592T2 (de)
ES (1) ES2061650T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions
DE69004081T2 (de) * 1990-05-23 1994-02-10 Nestle Sa Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
DE4022815A1 (de) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
GB9117140D0 (en) * 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5942241A (en) 1995-06-09 1999-08-24 Euro-Celtique, S.A. Formulations and methods for providing prolonged local anesthesia
JP3463442B2 (ja) * 1995-12-26 2003-11-05 ライオン株式会社 口腔用組成物
JPH11511763A (ja) 1996-06-24 1999-10-12 ユーロ―セルティーク，エス．エイ． 安全な局所麻酔の提供方法
DE19629433A1 (de) * 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US5885594A (en) * 1997-03-27 1999-03-23 The Procter & Gamble Company Oral compositions having enhanced mouth-feel
AU739384B2 (en) * 1997-07-02 2001-10-11 Euro-Celtique S.A. Prolonged anesthesia in joints and body spaces
US6191154B1 (en) * 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
EP1363602A4 (de) * 2001-01-25 2006-01-11 Euro Celtique Sa Lokalanästhetikum und anwendungsverfahren dafür
GB0111282D0 (en) * 2001-05-09 2001-06-27 Laxdale Ltd Potentiation of therapeutic effects of fatty acids
US20060134025A1 (en) * 2004-12-17 2006-06-22 Colgate-Palmolive Company Oral compositions containing extracts of Rosmarinus and related methods
US20060286199A1 (en) * 2005-06-03 2006-12-21 Marilou Laprise Method and composition for increasing omega-3 lipid in milk
US20090069426A1 (en) * 2005-11-18 2009-03-12 Hill's Pet Nutrition, Inc. Methods For Reducing The Amount Of A Proinflammatory Substance In Animal Tissue Or Body Fluid
US7669341B1 (en) 2006-01-23 2010-03-02 Kenneth Carazo Adjustable prism stand/pole
JP2018104301A (ja) * 2016-12-22 2018-07-05 花王株式会社 バイオフィルム形成抑制剤用顆粒の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215144A (en) * 1972-08-25 1980-07-29 Oxford Hill Ltd. Method of treating and controlling gingivitis
US4224307A (en) * 1978-06-26 1980-09-23 Oxford Hill, Ltd. Mouthwash and methods
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
NZ205076A (en) * 1982-08-09 1985-04-30 Univ California Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
EP0175468A3 (de) * 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoide zur Verwendung bei der Krebstherapie
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions

Also Published As

Publication number Publication date
JP2722204B2 (ja) 1998-03-04
ATE99171T1 (de) 1994-01-15
AU1770888A (en) 1988-12-22
EP0295954A3 (en) 1990-07-11
CA1330046C (en) 1994-06-07
EP0295954A2 (de) 1988-12-21
AU607509B2 (en) 1991-03-07
EP0295954B1 (de) 1993-12-29
ES2061650T3 (es) 1994-12-16
DE3886592T2 (de) 1994-04-07
JPH01139529A (ja) 1989-06-01
US5225441A (en) 1993-07-06

Similar Documents

Publication Publication Date Title
DE3886592T2 (de) Präparate zur Behandlung von Beschwerden der Wurzelhaut der Zähne.
DE3579126D1 (de) Minocylin in stabiler form enthaltendes mittel zur behandlung periodontaler erkrankungen.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
NL188205C (nl) Tandbehandelingsmiddel met werking tegen tandsteen.
DE68911103D1 (de) Verwendung von Fettsäuren zur Behandlung von myalgischer Enzephalomyelitis.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE69025270D1 (de) Verwendung von Monoolein bei der Behandlung der Periodontal- tasche
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3483330D1 (de) Mittel zur behandlung von erkrankungen der zahnwurzelhaut.
DE3885304T2 (de) Zubereitung für zahnbehandlung und verfahren zur herstellung.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
PT75856A (pt) Azolyl-penten-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
AT400095B (de) Zahnärztliches handstück für die behandlung von zähnen mit laserstrahlen
ATA258285A (de) Stabiles, zahnbelag verhinderndes zahnpflegemittel und verfahren zur herstellung desselben
DE3864040D1 (de) Zahnaerztliches handstueck.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
SE7901863L (sv) Medicinsk behandlingsstol, isynnerhet tandlekarstol
DE68905562T2 (de) Verfahren zur Herstellung des (+)-Isomers von Cloprostenol.
DE3877199T3 (de) Verfahren zur Behandlung der Kopfhaut.
DE68905479T2 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
ES1004314Y (es) Protesis dental amovible.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee